CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.56−0.06 (-1.79%)
Close on Oct 19, 2026Market cap $5.14MP/E –Yield –
CollPlant Biotechnologies gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $1.54M. The highest annual figure on record is $13.64M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54M | – |
| FY2024 | Dec 31, 2024 | -$1.11M | -112.4% |
| FY2023 | Dec 31, 2023 | $8.97M | – |
| FY2022 | Dec 31, 2022 | -$101.00K | -100.7% |
| FY2021 | Dec 31, 2021 | $13.64M | +335.0% |
| FY2020 | Dec 31, 2020 | $3.14M | +614.1% |
| FY2019 | Dec 31, 2019 | $439.00K | -86.9% |
| FY2018 | Dec 31, 2018 | $3.36M | +708.4% |
| FY2017 | Dec 31, 2017 | $415.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -$7.00K | -102.7% |
| Q2 FY2024 | Jun 30, 2024 | -$287.00K | -482.7% |
| Q2 FY2023 | Jun 30, 2023 | $9.57M | +6591.6% |
| Q2 FY2022 | Jun 30, 2022 | $23.00K | -80.0% |
| Q2 FY2021 | Jun 30, 2021 | $262.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $75.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $143.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $115.00K | – |
See a number that looks wrong?